Gedea Biotech Ab
Clinical trials sponsored by Gedea Biotech Ab, explained in plain language.
-
New Non-Antibiotic BV treatment shows promise in early safety testing
Disease control Recruiting nowThis study is testing the safety of a new vaginal tablet called pHyph for treating bacterial vaginosis (BV). Thirty-two women with BV will use the tablets for 12 days while researchers monitor for any side effects. The treatment aims to restore the vagina's natural acidity to hel…
Phase: NA • Sponsor: Gedea Biotech AB • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New Drug-Free tablet aims to soothe common yeast infection misery
Disease control Recruiting nowThis study is testing a new vaginal tablet called pHyph to see if it can reduce the itching, burning, and irritation of yeast infections (thrush). Researchers will compare women using the tablet for 6 days to women receiving no initial treatment to measure symptom relief. The stu…
Phase: NA • Sponsor: Gedea Biotech AB • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC